While the deal is material (cash proceeds and debt reduction), the associated ticker (CLVT) is not included in the active_symbols set, so no dashboard ticker can be selected.
Clarivate (CLVT) to Sell Life Sciences & Healthcare Business to Altaris For $600 Million Muhammad Ali Khalid Sun, July 12, 2026 at 7:21 PM GMT+2 2 min read CLVT Clarivate PLC (NYSE: CLVT ) is one of the 15 best NYSE penny stocks to buy according to hedge funds . On July 6, Clarivate PLC (NYSE:CLVT) disclosed that it signed a definitive agreement to sell its Life Sciences & Healthcare segment to Altaris for a consideration of around $600 million. Upon completion of this divestment, the company will become a subscription-first worldwide provider of technology-enabled services, intelligence solutions, and workflow software.
Wright Studio/Shutterstock. com The company plans to use the cash proceeds to reduce its existing debt. The payment structure comprises $500 million in cash payment, issuance of a $75 million seller note, and the remaining $25 million in deferred cash that will be linked with an agreement around transition services.
Back on June 15, Clarivate PLC (NYSE:CLVT) announced that the company's IPfolio Management Software has been chosen by Mitsubishi Fuso Truck and Bus Corporation as its intellectual property management solution. With highly integrated solutions, trusted data, and expert assistance, all in one platform, Mitsubishi Fuso now has access to an advanced platform for managing intellectual property. This will help them achieve enhanced decision-making and operational confidence.
On July 7, Manav Patnaik from Barclays increased his target price for the stock from $2. 40 to $2. 50, leading to a revised upside of more than 14%.
However, the analyst reaffirmed his Underweight rating on the stock. Clarivate PLC (NYSE:CLVT) offers information services worldwide. It provides scientific and academic solutions for studies.
These include databases, video-format dissertations, and more. It also provides administrative services such as Derwent Innovation and AI-powered search. While we acknowledge the potential of CLVT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk.
If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock . READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years . Disclosure: None.
Follow Insider Monkey on Google News .
Oraklio AI Trading Intelligence
Oraklio turns news, price data, and market signals into structured BUY / SELL / NO_TRADE calls - updated continuously throughout the trading day.
Get started freeAlready have an account? Sign in →